These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32013033)

  • 1. EVI1 as a Marker for Lymph Node Metastasis in HNSCC.
    Idel C; Ribbat-Idel J; Kuppler P; Krupar R; Offermann A; Vogel W; Rades D; Kirfel J; Wollenberg B; Perner S
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.
    Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ
    Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
    Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
    Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological features and prognostic significance of treatment effect in lymph node metastasis in head and neck squamous cell carcinoma.
    Scherpelz KP; Wong AC; Lingen MW; Taxy JB; Cipriani NA
    Histopathology; 2019 Jan; 74(2):321-331. PubMed ID: 30144145
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Grandits AM; Bromberger S; Heller G; Reinoehl BA; Tomasich E; Schossleitner K; Berghoff AS; Fuereder T; Wieser R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Markers Predicting Clinically Occult Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma.
    Gaudioso P; Borsetto D; Polesel J; Tirelli G; Emanuelli E; Menegaldo A; Molteni G; Nicolai P; Tomasoni M; Montenegro C; Piazza C; Bossi P; Ciorba A; Canzi P; Giacomarra V; Giudici F; Fussey J; Boscolo-Rizzo P
    ORL J Otorhinolaryngol Relat Spec; 2024; 86(1):32-40. PubMed ID: 37972574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome.
    Schneider S; Kadletz L; Wiebringhaus R; Kenner L; Selzer E; Füreder T; Rajky O; Berghoff AS; Preusser M; Heiduschka G
    Histopathology; 2018 Oct; 73(4):573-584. PubMed ID: 29742291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma.
    Li H; Xiao Y; Wu CC; Yang LL; Cao LY; Chen DR; Zhou JJ; Zhang WF; Sun ZJ
    Histol Histopathol; 2019 Jul; 34(7):803-810. PubMed ID: 30632601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
    Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.
    Wicker CA; Takiar V; Suganya R; Arnold SM; Brill YM; Chen L; Horbinski CM; Napier D; Valentino J; Kudrimoti MR; Yu G; Izumi T
    Oral Oncol; 2020 Dec; 111():104949. PubMed ID: 32801084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially expressed proteins in positive versus negative HNSCC lymph nodes.
    Vidotto A; Polachini GM; de Paula-Silva M; Oliani SM; Henrique T; López RVM; Cury PM; Nunes FD; Góis-Filho JF; de Carvalho MB; Leopoldino AM; Tajara EH
    BMC Med Genomics; 2018 Aug; 11(1):73. PubMed ID: 30157864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
    Huang L; David O; Cabay RJ; Valyi-Nagy K; Macias V; Zhong R; Wenig B; Feldman L; Weichselbaum R; Spiotto MT
    Clin Cancer Res; 2019 Mar; 25(6):1795-1808. PubMed ID: 30573692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
    Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of occult lymph node metastasis in squamous cell carcinoma of the oral cavity and the oropharynx using peritumoral Prospero homeobox protein 1 lymphatic nuclear quantification.
    Mermod M; Bongiovanni M; Petrova TV; Dubikovskaya EA; Simon C; Tolstonog G; Monnier Y
    Head Neck; 2016 Sep; 38(9):1407-15. PubMed ID: 27043718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patients.
    Kühn JP; Bochen F; Körner S; Schick B; Wagner M; Smola S; Berkó-Göttel B; Morris LGT; Wang J; Bozzato A; Linxweiler M
    Int J Biol Markers; 2022 Sep; 37(3):280-288. PubMed ID: 35880270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eps8 expression is significantly lower in p16
    Nasri E; Wiesen LB; Knapik JA; Fredenburg KM
    Hum Pathol; 2018 Feb; 72():45-51. PubMed ID: 29107665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Expression Comparison Between the Primary Tumor and its Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma: A Pilot Study.
    Karpathiou G; Stachowitz ML; Dumollard JM; Gavid M; Froudarakis M; Prades JM; Peoc'h M
    Cancer Genomics Proteomics; 2019; 16(3):155-161. PubMed ID: 31018946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
    de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
    BMC Med; 2015 May; 13():108. PubMed ID: 25956054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of SERPINH1 is associated with elevated expression in head and neck squamous cell carcinomas and its clinicopathological significance.
    Murugesan D; Kannan B; As SG; Jayaseelan VP; Arumugam P
    J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101811. PubMed ID: 38432483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.